Salarius Pharmaceuticals, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
SLRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2450 Holcombe Blvd, Suite J 608, Houston, Texas

There are no Buy or Sell transactions made by insiders since 8/26/2023

Salarius Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Arnold C. Hanish Director Feb 20, 2024
Jonathan I. Lieber Director Feb 20, 2024
David J. Arthur Chief Executive Officer, Director Apr 11, 2024
Tess Burleson Director Feb 20, 2024
William K. McVicar Director Feb 20, 2024
Bruce J. McCreedy Jr. Director Feb 20, 2024
Mark J. Rosenblum Exec VP Finance, CFO Feb 20, 2024
Paul Lammers Director Feb 20, 2024

Recent Insider Transactions by Companies or Individuals for Salarius Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.